Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Education

ChristianaCare is an Approved Portfolio Sponsor of the ABMS Maintenance of Certification Multi-Specialty Portfolio Program

On behalf of the American Board of Medical Specialties and participating Member Boards, the Multi-Specialty Portfolio Approval Program has approved ChristianaCare as a portfolio sponsor.

As a portfolio sponsor, ChristianaCare is granted authority to approve internal quality improvement efforts as meeting portfolio program standards and guidelines, thus allowing participating physicians to submit their project completions for MOC Part IV from their participating specialty board.

How to apply for MOC Approval of a quality improvement effort

Prior to making application for project approval, please review the standards and guidelines for MOC qualifying QI initiatives to make certain your QI project meets these requirements, and additionally review the standards and guidelines for meaningful participation in qualifying QI initiatives and communicate these requirements to physician members of the team.

If clarification of additional information is needed, contact the CME MOC committee representative at MOC@christianacare.org.

The CME MOC portfolio program committee will review each application and provide feedback within 30 days. The committee will assist initiative leaders and team members in meeting standards and requirements.

ABMS deadlines for 2021

New QI Activity – October 1, 2021
Physician completions – November 15, 2021